Search research articles
Contact Us
Filters
Showing results (131-140 of 144) with videos related to
Page
of 15
Sort By:
Inflammatory Bowel Diseases
|
November 1, 2011
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report
Brian G Feagan, Marc Lémann, Ragnar Befrits, et al.
Journal of Crohn'S & Colitis
|
February 14, 2012
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus
Walter Reinisch, Gert Van Assche, Ragnar Befrits, et al.
Journal of Crohn'S & Colitis
|
December 22, 2010
European evidence-based Consensus on the management of ulcerative colitis: Special situations
Livia Biancone, Pierre Michetti, Simon Travis, et al.
Nature Medicine
|
January 22, 2019
Microbial network disturbances in relapsing refractory Crohn's disease
Bahtiyar Yilmaz, Pascal Juillerat, Ove Øyås, et al.
Nature Medicine
|
March 9, 2019
Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease
Bahtiyar Yilmaz, Pascal Juillerat, Ove Øyås, et al.
European Journal of Gastroenterology & Hepatology
|
November 1, 2022
Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease
Maude Martinho-Grueber, Ioannis Kapoglou, Francisco Bravo, et al.
Inflammatory Bowel Diseases
|
May 29, 2015
Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort
Stephan R Vavricka, Gerhard Rogler, Claudine Gantenbein, et al.
Journal of the Canadian Association of Gastroenterology
|
October 5, 2022
Efficacy of Intravenous Ustekinumab Reinduction in Patients With Crohn's Disease With a Loss of Response
Valerie Heron, Steven Li Fraine, Nicola Panaccione, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 4, 2015
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents
Pauline Wils, Yoram Bouhnik, Pierre Michetti, et al.
Inflammatory Intestinal Diseases
|
July 19, 2018
Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)
Ekaterina Safroneeva, Catherine Saner, Jean-Benoît Rossel, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 144) with videos related to
Sort By:
Page
of 15
Inflammatory Bowel Diseases
|
November 1, 2011
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report
Brian G Feagan, Marc Lémann, Ragnar Befrits, et al.
Journal of Crohn'S & Colitis
|
February 14, 2012
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus
Walter Reinisch, Gert Van Assche, Ragnar Befrits, et al.
Journal of Crohn'S & Colitis
|
December 22, 2010
European evidence-based Consensus on the management of ulcerative colitis: Special situations
Livia Biancone, Pierre Michetti, Simon Travis, et al.
Nature Medicine
|
January 22, 2019
Microbial network disturbances in relapsing refractory Crohn's disease
Bahtiyar Yilmaz, Pascal Juillerat, Ove Øyås, et al.
Nature Medicine
|
March 9, 2019
Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease
Bahtiyar Yilmaz, Pascal Juillerat, Ove Øyås, et al.
European Journal of Gastroenterology & Hepatology
|
November 1, 2022
Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease
Maude Martinho-Grueber, Ioannis Kapoglou, Francisco Bravo, et al.
Inflammatory Bowel Diseases
|
May 29, 2015
Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort
Stephan R Vavricka, Gerhard Rogler, Claudine Gantenbein, et al.
Journal of the Canadian Association of Gastroenterology
|
October 5, 2022
Efficacy of Intravenous Ustekinumab Reinduction in Patients With Crohn's Disease With a Loss of Response
Valerie Heron, Steven Li Fraine, Nicola Panaccione, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 4, 2015
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents
Pauline Wils, Yoram Bouhnik, Pierre Michetti, et al.
Inflammatory Intestinal Diseases
|
July 19, 2018
Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)
Ekaterina Safroneeva, Catherine Saner, Jean-Benoît Rossel, et al.
Page
of 15